According to the research report published by Market IntelliX, the global market for Sustained-release Medicine should grow from US$ 34850 million in 2022 to US$ 55040 million by 2029, with a CAGR of 6.9% for the period of 2023-2029.

The main global manufacturers of sustained-release drugs are Sanofi, Novartis, Bayer, Johnson & Johnson, Takeda, AstraZeneca, AbbVie, etc. The top seven manufacturers occupy a total market share of nearly 35%, of which the largest manufacturer is Sanofi, with a market share of 10.85%. Global sustained-release drug production regions are mainly located in Europe, the United States, China, etc., of which the top two regions occupy more than 65% of the market share. In terms of their product categories, original ground medicine have a higher market share of 63.96%, while generics have a lower share.

Sustained-release Medicine refer to preparations that can be continuously released for a long time after administration to achieve long-acting effects, and the drug release is mainly a first-order rate process. Controlled release preparations (controlled release preparations) refer to the preparations that can automatically release the drug at a predetermined speed within a predetermined time, so that the blood drug concentration can be kept constant within the effective concentration range for a long time.

Since there is no difference between sustained-release preparations and controlled-release preparations in the some countries, so, in this report, Extended release (ER), Sustained release (SR), Controlled release (CR) and Delayed release (D

This report aims to provide a comprehensive study of the global market for Sustained-release Medicine. Report Highlights:

(1) Global Sustained-release Medicine market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Sustained-release Medicine market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Sustained-release Medicine market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Sustained-release Medicine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Sustained-release Medicine segment by type and by application and regional segment by type and by application.

(6) Sustained-release Medicine industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Original Ground Medicine

Generic Medicine

Market segment by distribution channel, can be divided into

Hospital

Drugstore

Other

Market segment by players, this report covers

Sanofi

Novartis

Bayer

Johnson & Johnson

Takeda

AstraZeneca

AbbVie

Pfizer

Collegium Pharmaceutical, Inc

Endo Pharmaceuticals

Shanghai Shyndec Pharmaceutical

Zhuhai Rundu Pharmaceutical

China Res Double-Crane

1 Market Overview

1.1 Product Overview and Scope of Sustained-release Medicine

1.2 Global Sustained-release Medicine Market Size and Forecast

1.3 China Sustained-release Medicine Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Sustained-release Medicine Share in Global Market, 2018-2029

1.4.2 Sustained-release Medicine Market Size: China VS Global, 2018-2029

1.5 Sustained-release Medicine Market Dynamics

1.5.1 Sustained-release Medicine Market Drivers

1.5.2 Sustained-release Medicine Market Restraints

1.5.3 Sustained-release Medicine Industry Trends

1.5.4 Sustained-release Medicine Industry Policy

2 Global Competitive Situation by Company

2.1 Global Sustained-release Medicine Revenue by Company (2018-2023)

2.2 Global Sustained-release Medicine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Sustained-release Medicine Concentration Ratio

2.4 Global Sustained-release Medicine Mergers & Acquisitions, Expansion Plans

2.5 Global Sustained-release Medicine Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Sustained-release Medicine Revenue by Company (2018-2023)

3.2 China Sustained-release Medicine Sustained-release Medicine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Sustained-release Medicine, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Sustained-release Medicine Industry Chain

4.2 Sustained-release Medicine Upstream Analysis

4.3 Sustained-release Medicine Midstream Analysis

4.4 Sustained-release Medicine Downstream Analysis

5 Sights by Type

5.1 Sustained-release Medicine Classification

5.1.1 Original Ground Medicine

5.1.2 Generic Medicine

5.2 By Type, Global Sustained-release Medicine Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Sustained-release Medicine Revenue, 2018-2029

6 Sights by Distribution Channel

6.1 Sustained-release Medicine Segment by Distribution Channel

6.1.1 Hospital

6.1.2 Drugstore

6.1.3 Other

6.2 By Application, Global Sustained-release Medicine Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Sustained-release Medicine Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Sustained-release Medicine Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Sustained-release Medicine Market Size, 2018-2029

7.3 North America

7.3.1 North America Sustained-release Medicine Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Sustained-release Medicine Market Size Market Share

7.4 Europe

7.4.1 Europe Sustained-release Medicine Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Sustained-release Medicine Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Sustained-release Medicine Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Sustained-release Medicine Market Size Market Share

7.6 South America

7.6.1 South America Sustained-release Medicine Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Sustained-release Medicine Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Sustained-release Medicine Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Sustained-release Medicine Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Sustained-release Medicine Market Size, 2018-2029

8.3.2 By Company, U.S. Sustained-release Medicine Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.3.4 By Distribution Channel, U.S. Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Sustained-release Medicine Market Size, 2018-2029

8.4.2 By Company, Europe Sustained-release Medicine Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.4.4 By Distribution Channel, Europe Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Sustained-release Medicine Market Size, 2018-2029

8.5.2 By Company, China Sustained-release Medicine Revenue Market Share, 2018-2023

8.5.3 By Type, China Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.5.4 By Distribution Channel, China Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Sustained-release Medicine Market Size, 2018-2029

8.6.2 By Company, Japan Sustained-release Medicine Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.6.4 By Distribution Channel, Japan Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Sustained-release Medicine Market Size, 2018-2029

8.7.2 By Company, South Korea Sustained-release Medicine Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.7.4 By Distribution Channel, South Korea Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Sustained-release Medicine Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Sustained-release Medicine Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.8.4 By Distribution Channel, Southeast Asia Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Sustained-release Medicine Market Size, 2018-2029

8.9.2 By Company, India Sustained-release Medicine Revenue Market Share, 2018-2023

8.9.3 By Type, India Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.9.4 By Distribution Channel, India Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Sustained-release Medicine Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Sustained-release Medicine Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.10.4 By Distribution Channel, Middle East & Asia Sustained-release Medicine Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Sanofi

9.1.1 Sanofi Company Information, Head Office, Market Area and Industry Position

9.1.2 Sanofi Company Profile and Main Business

9.1.3 Sanofi Sustained-release Medicine Models, Specifications and Application

9.1.4 Sanofi Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.1.5 Sanofi Recent Developments

9.2 Novartis

9.2.1 Novartis Company Information, Head Office, Market Area and Industry Position

9.2.2 Novartis Company Profile and Main Business

9.2.3 Novartis Sustained-release Medicine Models, Specifications and Application

9.2.4 Novartis Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.2.5 Novartis Recent Developments

9.3 Bayer

9.3.1 Bayer Company Information, Head Office, Market Area and Industry Position

9.3.2 Bayer Company Profile and Main Business

9.3.3 Bayer Sustained-release Medicine Models, Specifications and Application

9.3.4 Bayer Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.3.5 Bayer Recent Developments

9.4 Johnson & Johnson

9.4.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

9.4.2 Johnson & Johnson Company Profile and Main Business

9.4.3 Johnson & Johnson Sustained-release Medicine Models, Specifications and Application

9.4.4 Johnson & Johnson Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.4.5 Johnson & Johnson Recent Developments

9.5 Takeda

9.5.1 Takeda Company Information, Head Office, Market Area and Industry Position

9.5.2 Takeda Company Profile and Main Business

9.5.3 Takeda Sustained-release Medicine Models, Specifications and Application

9.5.4 Takeda Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.5.5 Takeda Recent Developments

9.6 AstraZeneca

9.6.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position

9.6.2 AstraZeneca Company Profile and Main Business

9.6.3 AstraZeneca Sustained-release Medicine Models, Specifications and Application

9.6.4 AstraZeneca Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.6.5 AstraZeneca Recent Developments

9.7 AbbVie

9.7.1 AbbVie Company Information, Head Office, Market Area and Industry Position

9.7.2 AbbVie Company Profile and Main Business

9.7.3 AbbVie Sustained-release Medicine Models, Specifications and Application

9.7.4 AbbVie Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.7.5 AbbVie Recent Developments

9.8 Pfizer

9.8.1 Pfizer Company Information, Head Office, Market Area and Industry Position

9.8.2 Pfizer Company Profile and Main Business

9.8.3 Pfizer Sustained-release Medicine Models, Specifications and Application

9.8.4 Pfizer Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.8.5 Pfizer Recent Developments

9.9 Collegium Pharmaceutical, Inc

9.9.1 Collegium Pharmaceutical, Inc Company Information, Head Office, Market Area and Industry Position

9.9.2 Collegium Pharmaceutical, Inc Company Profile and Main Business

9.9.3 Collegium Pharmaceutical, Inc Sustained-release Medicine Models, Specifications and Application

9.9.4 Collegium Pharmaceutical, Inc Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.9.5 Collegium Pharmaceutical, Inc Recent Developments

9.10 Endo Pharmaceuticals

9.10.1 Endo Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

9.10.2 Endo Pharmaceuticals Company Profile and Main Business

9.10.3 Endo Pharmaceuticals Sustained-release Medicine Models, Specifications and Application

9.10.4 Endo Pharmaceuticals Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.10.5 Endo Pharmaceuticals Recent Developments

9.11 Shanghai Shyndec Pharmaceutical

9.11.1 Shanghai Shyndec Pharmaceutical Company Information, Head Office, Market Area and Industry Position

9.11.2 Shanghai Shyndec Pharmaceutical Company Profile and Main Business

9.11.3 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Models, Specifications and Application

9.11.4 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.11.5 Shanghai Shyndec Pharmaceutical Recent Developments

9.12 Zhuhai Rundu Pharmaceutical

9.12.1 Zhuhai Rundu Pharmaceutical Company Information, Head Office, Market Area and Industry Position

9.12.2 Zhuhai Rundu Pharmaceutical Company Profile and Main Business

9.12.3 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Models, Specifications and Application

9.12.4 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.12.5 Zhuhai Rundu Pharmaceutical Recent Developments

9.13 China Res Double-Crane

9.13.1 China Res Double-Crane Company Information, Head Office, Market Area and Industry Position

9.13.2 China Res Double-Crane Company Profile and Main Business

9.13.3 China Res Double-Crane Sustained-release Medicine Models, Specifications and Application

9.13.4 China Res Double-Crane Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.13.5 China Res Double-Crane Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Sustained-release Medicine Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Sustained-release Medicine Market Restraints

Table 3. Sustained-release Medicine Market Trends

Table 4. Sustained-release Medicine Industry Policy

Table 5. Global Sustained-release Medicine Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Sustained-release Medicine Revenue Market Share by Company (2018-2023)

Table 7. Global Sustained-release Medicine Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Sustained-release Medicine Mergers & Acquisitions, Expansion Plans

Table 9. Global Sustained-release Medicine Manufacturers Product Type

Table 10. China Sustained-release Medicine Revenue by Company (2018-2023) & (US$ million)

Table 11. China Sustained-release Medicine Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Sustained-release Medicine Upstream (Raw Materials)

Table 13. Global Sustained-release Medicine Typical Customers

Table 14. Sustained-release Medicine Typical Distributors

Table 15. By Type, Global Sustained-release Medicine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Distribution Channel, Global Sustained-release Medicine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Sustained-release Medicine Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Sustained-release Medicine Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Sustained-release Medicine Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Sustained-release Medicine Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Sustained-release Medicine Revenue Market Share, 2018-2029

Table 22. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 23. Sanofi Company Profile and Main Business

Table 24. Sanofi Sustained-release Medicine Models, Specifications and Application

Table 25. Sanofi Sustained-release Medicine Revenue and Gross Margin, 2018-2023

Table 26. Sanofi Recent Developments

Table 27. Novartis Company Information, Head Office, Market Area and Industry Position

Table 28. Novartis Company Profile and Main Business

Table 29. Novartis Sustained-release Medicine Models, Specifications and Application

Table 30. Novartis Sustained-release Medicine Revenue and Gross Margin, 2018-2023

Table 31. Novartis Recent Developments

Table 32. Bayer Company Information, Head Office, Market Area and Industry Position

Table 33. Bayer Company Profile and Main Business

Table 34. Bayer Sustained-release Medicine Models, Specifications and Application

Table 35. Bayer Sustained-release Medicine Revenue and Gross Margin, 2018-2023

Table 36. Bayer Recent Developments

Table 37. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

Table 38. Johnson & Johnson Company Profile and Main Business

Table 39. Johnson & Johnson Sustained-release Medicine Models, Specifications and Application

Table 40. Johnson & Johnson Sustained-release Medicine Revenue and Gross Margin, 2018-2023

Table 41. Johnson & Johnson Recent Developments

Table 42. Takeda Company Information, Head Office, Market Area and Industry Position

Table 43. Takeda Company Profile and Main Business

Table 44. Takeda Sustained-release Medicine Models, Specifications and Application

Table 45. Takeda Sustained-release Medicine Revenue and Gross Margin, 2018-2023

Table 46. Takeda Recent Developments

Table 47. AstraZeneca Company Information, Head Office, Market Area and Industry Position

Table 48. AstraZeneca Company Profile and Main Business

Table 49. AstraZeneca Sustained-release Medicine Models, Specifications and Application

Table 50. AstraZeneca Sustained-release Medicine Revenue and Gross Margin, 2018-2023

Table 51. AstraZeneca Recent Developments

Table 52. AbbVie Company Information, Head Office, Market Area and Industry Position

Table 53. AbbVie Company Profile and Main Business

Table 54. AbbVie Sustained-release Medicine Models, Specifications and Application

Table 55. AbbVie Sustained-release Medicine Revenue and Gross Margin, 2018-2023

Table 56. AbbVie Recent Developments

Table 57. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 58. Pfizer Company Profile and Main Business

Table 59. Pfizer Sustained-release Medicine Models, Specifications and Application

Table 60. Pfizer Sustained-release Medicine Revenue and Gross Margin, 2018-2023

Table 61. Pfizer Recent Developments

Table 62. Collegium Pharmaceutical, Inc Company Information, Head Office, Market Area and Industry Position

Table 63. Collegium Pharmaceutical, Inc Company Profile and Main Business

Table 64. Collegium Pharmaceutical, Inc Sustained-release Medicine Models, Specifications and Application

Table 65. Collegium Pharmaceutical, Inc Sustained-release Medicine Revenue and Gross Margin, 2018-2023

Table 66. Collegium Pharmaceutical, Inc Recent Developments

Table 67. Endo Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 68. Endo Pharmaceuticals Company Profile and Main Business

Table 69. Endo Pharmaceuticals Sustained-release Medicine Models, Specifications and Application

Table 70. Endo Pharmaceuticals Sustained-release Medicine Revenue and Gross Margin, 2018-2023

Table 71. Endo Pharmaceuticals Recent Developments

Table 72. Shanghai Shyndec Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 73. Shanghai Shyndec Pharmaceutical Company Profile and Main Business

Table 74. Shanghai Shyndec Pharmaceutical Sustained-release Medicine Models, Specifications and Application

Table 75. Shanghai Shyndec Pharmaceutical Sustained-release Medicine Revenue and Gross Margin, 2018-2023

Table 76. Shanghai Shyndec Pharmaceutical Recent Developments

Table 77. Zhuhai Rundu Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 78. Zhuhai Rundu Pharmaceutical Company Profile and Main Business

Table 79. Zhuhai Rundu Pharmaceutical Sustained-release Medicine Models, Specifications and Application

Table 80. Zhuhai Rundu Pharmaceutical Sustained-release Medicine Revenue and Gross Margin, 2018-2023

Table 81. Zhuhai Rundu Pharmaceutical Recent Developments

Table 82. China Res Double-Crane Company Information, Head Office, Market Area and Industry Position

Table 83. China Res Double-Crane Company Profile and Main Business

Table 84. China Res Double-Crane Sustained-release Medicine Models, Specifications and Application

Table 85. China Res Double-Crane Sustained-release Medicine Revenue and Gross Margin, 2018-2023

Table 86. China Res Double-Crane Recent Developments

List of Figure

Figure 1. Sustained-release Medicine Picture

Figure 2. Global Sustained-release Medicine Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Sustained-release Medicine Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Sustained-release Medicine Market Share of Global

Figure 5. Global Sustained-release Medicine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Sustained-release Medicine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Sustained-release Medicine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Sustained-release Medicine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Sustained-release Medicine Industry Chain

Figure 10. Original Ground Medicine

Figure 11. Generic Medicine

Figure 12. By Type, Global Sustained-release Medicine Revenue, 2018-2029, US$ Million

Figure 13. By Type, Global Sustained-release Medicine Revenue Market Share, 2018-2029

Figure 14. Hospital

Figure 15. Drugstore

Figure 16. Other

Figure 17. By Distribution Channel, Global Sustained-release Medicine Revenue, 2018-2029, US$ Million

Figure 18. By Distribution Channel, Global Sustained-release Medicine Revenue Market Share, 2018-2029

Figure 19. By Region, Global Sustained-release Medicine Revenue Market Share, 2018-2029

Figure 20. North America Sustained-release Medicine Revenue & Forecasts, 2018-2029, US$ Million

Figure 21. By Country, North America Sustained-release Medicine Revenue Market Share, 2018-2023

Figure 22. Europe Sustained-release Medicine Revenue & Forecasts, 2018-2029, US$ Million

Figure 23. By Country, Europe Sustained-release Medicine Revenue Market Share, 2018-2023

Figure 24. Asia Pacific Sustained-release Medicine Revenue & Forecasts, 2018-2029, US$ Million

Figure 25. By Country/Region, Asia Pacific Sustained-release Medicine Revenue Market Share, 2018-2023

Figure 26. South America Sustained-release Medicine Revenue & Forecasts, 2018-2029, US$ Million

Figure 27. By Country, South America Sustained-release Medicine Revenue Market Share, 2018-2023

Figure 28. Middle East & Africa Sustained-release Medicine Revenue & Forecasts, 2018-2029, US$ Million

Figure 29. U.S. Sustained-release Medicine Revenue, 2018-2029, (US$ Million)

Figure 30. By Company, U.S. Sustained-release Medicine Market Share, 2018-2023

Figure 31. By Type, U.S. Sustained-release Medicine Revenue Market Share, 2022 VS 2029

Figure 32. By Distribution Channel, U.S. Sustained-release Medicine Revenue Market Share, 2022 VS 2029

Figure 33. Europe Sustained-release Medicine Revenue, 2018-2029, (US$ Million)

Figure 34. By Company, Europe Sustained-release Medicine Market Share, 2018-2023

Figure 35. By Type, Europe Sustained-release Medicine Revenue Market Share, 2022 VS 2029

Figure 36. By Distribution Channel, Europe Sustained-release Medicine Revenue Market Share, 2022 VS 2029

Figure 37. China Sustained-release Medicine Revenue, 2018-2029, (US$ Million)

Figure 38. By Company, China Sustained-release Medicine Market Share, 2018-2023

Figure 39. By Type, China Sustained-release Medicine Revenue Market Share, 2022 VS 2029

Figure 40. By Distribution Channel, China Sustained-release Medicine Revenue Market Share, 2022 VS 2029

Figure 41. Japan Sustained-release Medicine Revenue, 2018-2029, (US$ Million)

Figure 42. By Company, Japan Sustained-release Medicine Market Share, 2018-2023

Figure 43. By Type, Japan Sustained-release Medicine Revenue Market Share, 2022 VS 2029

Figure 44. By Distribution Channel, Japan Sustained-release Medicine Revenue Market Share, 2022 VS 2029

Figure 45. South Korea Sustained-release Medicine Revenue, 2018-2029, (US$ Million)

Figure 46. By Company, South Korea Sustained-release Medicine Market Share, 2018-2023

Figure 47. By Type, South Korea Sustained-release Medicine Revenue Market Share, 2022 VS 2029

Figure 48. By Distribution Channel, South Korea Sustained-release Medicine Revenue Market Share, 2022 VS 2029

Figure 49. Southeast Asia Sustained-release Medicine Revenue, 2018-2029, (US$ Million)

Figure 50. By Company, Southeast Asia Sustained-release Medicine Market Share, 2018-2023

Figure 51. By Type, Southeast Asia Sustained-release Medicine Revenue Market Share, 2022 VS 2029

Figure 52. By Distribution Channel, Southeast Asia Sustained-release Medicine Revenue Market Share, 2022 VS 2029

Figure 53. India Sustained-release Medicine Revenue, 2018-2029, (US$ Million)

Figure 54. By Company, India Sustained-release Medicine Market Share, 2018-2023

Figure 55. By Type, India Sustained-release Medicine Revenue Market Share, 2022 VS 2029

Figure 56. By Distribution Channel, India Sustained-release Medicine Revenue Market Share, 2022 VS 2029

Figure 57. Middle East & Asia Sustained-release Medicine Revenue, 2018-2029, (US$ Million)

Figure 58. By Company, Middle East & Asia Sustained-release Medicine Market Share, 2018-2023

Figure 59. By Type, Middle East & Asia Sustained-release Medicine Revenue Market Share, 2022 VS 2029

Figure 60. By Distribution Channel, Middle East & Asia Sustained-release Medicine Revenue Market Share, 2022 VS 2029

Figure 61. Research Methodology

Figure 62. Breakdown of Primary Interviews

Figure 63. Bottom-up Approaches

Figure 64. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)